![Mark Throsby](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Throsby
Vorstandsvorsitzender bei
ATB Therapeutics
Profil
Mark Throsby is Chief Executive Officer at ATB Therapeutics SA since 2026.
Dr. Throsby is Chairman at Alethiomics Ltd. Dr. Throsby is Independent Director at Ona Therapeutics SL since 2021.
Dr. Throsby is Chief Operating & Scientific Officer at Gadeta BV since 2020.
Dr. Throsby was Director-Antibody Discovery at Crucell NV from 2000 to 2008.
Dr. Throsby was Chief Scientific Officer & Executive VP at Merus NV from 2013 to 2020.
Dr. Throsby earned a doctorate from Monash University.
Aktive Positionen von Mark Throsby
| Unternehmen | Position | Beginn |
|---|---|---|
Ona Therapeutics SL
 Ona Therapeutics SL Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets drugs for treatment and cancers and other diseases | Direktor/Vorstandsmitglied | 05.03.2021 |
Alethiomics Ltd.
 Alethiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Vorsitzender | - |
Gadeta BV
 Gadeta BV BiotechnologyHealth Technology Conducts research and develops medicines & treatment methods for cancer | Geschäftsführer | 01.10.2020 |
ATB Therapeutics
 ATB Therapeutics BiotechnologyHealth Technology Develops novel therapeutic solutions for patients with cancer and auto-immune disease | Vorstandsvorsitzender | 13.05.2026 |
Ehemalige bekannte Positionen von Mark Throsby
| Unternehmen | Position | Ende |
|---|---|---|
| MERUS N.V. | Geschäftsführer | 01.01.2013 |
Crucell NV
 Crucell NV Pharmaceuticals: MajorHealth Technology Develops, produces and markets vaccines, proteins and antibodies | Corporate Officer/Principal | 28.10.2008 |
Ausbildung von Mark Throsby
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
48
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Develops, produces and markets vaccines, proteins and antibodies | Health Technology |
Monash University
 Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merus NV
 Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Gadeta BV
Gadeta BV BiotechnologyHealth Technology Conducts research and develops medicines & treatment methods for cancer | Health Technology |
Ona Therapeutics SL
Ona Therapeutics SL Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets drugs for treatment and cancers and other diseases | Health Technology |
ATB Therapeutics
ATB Therapeutics BiotechnologyHealth Technology Develops novel therapeutic solutions for patients with cancer and auto-immune disease | Health Technology |
Alethiomics Ltd.
Alethiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
